PRESS RELEASES

4 June 2020

CEBINA secures seed funding for its unique extended spectrum Coronavirus vaccine


Read more

17 April 2020

CEBINA today announces the initiation of several collaborative projects that address the global health crisis caused by the pandemic spread of the SARS-CoV-2 virus

Read more

2 June 2020

Eveliqure Biotechnologies announces regulatory approval to initiate first clinical trial of its ShigETEC vaccine candidate Biotechnologies 
Read more

4 March 2020

Calyxha Biotechnologies announces new financing to support pre-clinical development of its therapeutic lead candidate, CAL-X

Read more

20 April 2020

Calyxha Biotechnologies announces grant of a European Patent on neurodegenerative diseases


Read more

5 November 2020

Eveliqure Biotechnologies GmbH announces a grant from the Wellcome Trust to support their effort to develop a Shigella-ETEC combination vaccine for travelers and children in resource poor countries

Read more